Fig. 1From: Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial – the PRODIGE 22 - ECKINOXE trialProtocol overview. Temporal sequence of trial conduct in patients with RAS WT colon tumor (1A) or RAS mutated colon tumor (1B)Back to article page